A Update on COVID-19:

Personal Genome Diagnostics (PGDx) Communication in Response to COVID-19

To Our Valued Partners,

The global escalation of the COVID-19 outbreak has caused an unsettling situation with a massive impact on our lives. To protect the health and safety of our staff, clients and the general public, we have been closely monitoring information and adhering to the ever-changing guidelines and mandates from the State of Maryland, CDC and WHO. 

On March 23, 2020, Governor Hogan signed an executive order closing non-essential businesses across the State of Maryland. Though PGDx was forced to scale back on-site operations, we are able to maintain critical testing through our CLIA lab. 

The majority of our team continues to work remotely—dedicated to our commitments to you and the patients you serve.  

We are available to answer any questions you may have regarding the status of current and future projects. Do not hesitate to reach out to us:  

CAP/CLIA Lab Services

• Phone: (443) 602-8833
• Email: CRServices@pgdx.com 

Customer/Technical Support:

• Phone: (855)-PGDxNow (855-743-9669)
• Email: techservice@pgdx.com 

Sales:

• Online Form: https://www.personalgenome.com/contact
• Email: marketing@pgdx.com 

Rest assured, we remain dedicated to Empowering the Fight Against Cancer. Thank you for your partnership, patience, and collaboration as we all try to get through this unprecedented time.

Our Sincerest and Best Wishes to You and Yours,

Megan Bailey, MPH
Chief Commercial Officer, Personal Genome Diagnostics (PGDx)